Putting Patients First – to screen or not to screen?
Despite evident benefits in population screening, such programmes are slow to develop.

On the role of the Pharmacist in Near Patient Testing with In Vitro Diagnostics
Practical issues surrounding the tests available for Near Patient Testing

In vitro diagnostics in the next five years - A personal look to the future
Doris-Ann Williams Director General of BIVDA takes a personal view of the future of diagnostics. Article published in Clinical Laboratory International (CLI) September 2002.

Pharmacogenomics - 21st Century IVDs.
In the USA alone, one hundred billion dollars, or around ten percent of the health care budget, is spent on drugs.